These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 22404225)

  • 1. Studies on the interactions between β2 adrenergic receptor and Gs protein by molecular dynamics simulations.
    Feng Z; Hou T; Li Y
    J Chem Inf Model; 2012 Apr; 52(4):1005-14. PubMed ID: 22404225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational study on the different ligands induced conformation change of β2 adrenergic receptor-Gs protein complex.
    Bai Q; Zhang Y; Ban Y; Liu H; Yao X
    PLoS One; 2013; 8(7):e68138. PubMed ID: 23922653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Position of transmembrane helix 6 determines receptor G protein coupling specificity.
    Rose AS; Elgeti M; Zachariae U; Grubmüller H; Hofmann KP; Scheerer P; Hildebrand PW
    J Am Chem Soc; 2014 Aug; 136(32):11244-7. PubMed ID: 25046433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of β
    Ma X; Hu Y; Batebi H; Heng J; Xu J; Liu X; Niu X; Li H; Hildebrand PW; Jin C; Kobilka BK
    Proc Natl Acad Sci U S A; 2020 Sep; 117(37):23096-23105. PubMed ID: 32868434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic behavior of fully solvated beta2-adrenergic receptor, embedded in the membrane with bound agonist or antagonist.
    Spijker P; Vaidehi N; Freddolino PL; Hilbers PA; Goddard WA
    Proc Natl Acad Sci U S A; 2006 Mar; 103(13):4882-7. PubMed ID: 16551744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor.
    Goetz A; Lanig H; Gmeiner P; Clark T
    J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docking and MD study of histamine H4R based on the crystal structure of H1R.
    Feng Z; Hou T; Li Y
    J Mol Graph Model; 2013 Feb; 39():1-12. PubMed ID: 23220277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and characterization of pepducins as Gs-biased allosteric agonists.
    Carr R; Du Y; Quoyer J; Panettieri RA; Janz JM; Bouvier M; Kobilka BK; Benovic JL
    J Biol Chem; 2014 Dec; 289(52):35668-84. PubMed ID: 25395624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between G-Protein-Stabilized Agonist-GPCR Complexes and their Nanobody-Stabilized Equivalents.
    Saleh N; Ibrahim P; Clark T
    Angew Chem Int Ed Engl; 2017 Jul; 56(31):9008-9012. PubMed ID: 28481446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular dynamics of a biophysical model for beta2-adrenergic and G protein-coupled receptor activation.
    Rubenstein LA; Zauhar RJ; Lanzara RG
    J Mol Graph Model; 2006 Dec; 25(4):396-409. PubMed ID: 16574446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying conformational changes in GPCRs: glimpse of a common functional mechanism.
    Dalton JA; Lans I; Giraldo J
    BMC Bioinformatics; 2015 Apr; 16(1):124. PubMed ID: 25902715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational Modeling and Characterization of Peptides Derived from Nanobody Complementary-Determining Region 2 (CDR2) Targeting Active-State Conformation of the β
    Sencanski M; Glisic S; Kubale V; Cotman M; Mavri J; Vrecl M
    Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the conformational perturbations of novel agonists with β3-adrenergic receptor using molecular dynamics simulations.
    Tewatia P; Agrawal N; Gaur M; Sahi S
    Biochimie; 2014 Jun; 101():168-82. PubMed ID: 24508605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural insights into binding specificity, efficacy and bias of a β
    Masureel M; Zou Y; Picard LP; van der Westhuizen E; Mahoney JP; Rodrigues JPGLM; Mildorf TJ; Dror RO; Shaw DE; Bouvier M; Pardon E; Steyaert J; Sunahara RK; Weis WI; Zhang C; Kobilka BK
    Nat Chem Biol; 2018 Nov; 14(11):1059-1066. PubMed ID: 30327561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function.
    Rosenbaum DM; Cherezov V; Hanson MA; Rasmussen SG; Thian FS; Kobilka TS; Choi HJ; Yao XJ; Weis WI; Stevens RC; Kobilka BK
    Science; 2007 Nov; 318(5854):1266-73. PubMed ID: 17962519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the effects on constitutive activation and drug binding of a D130N mutation in the β2 adrenergic receptor via molecular dynamics simulation.
    Zhu Y; Yuan Y; Xiao X; Zhang L; Guo Y; Pu X
    J Mol Model; 2014 Nov; 20(11):2491. PubMed ID: 25342155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of conformational ensembles in ligand recognition in G-protein coupled receptors.
    Niesen MJ; Bhattacharya S; Vaidehi N
    J Am Chem Soc; 2011 Aug; 133(33):13197-204. PubMed ID: 21766860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling GPCR active state conformations: the β(2)-adrenergic receptor.
    Simpson LM; Wall ID; Blaney FE; Reynolds CA
    Proteins; 2011 May; 79(5):1441-57. PubMed ID: 21337626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural features of β2 adrenergic receptor: crystal structures and beyond.
    Bang I; Choi HJ
    Mol Cells; 2015; 38(2):105-11. PubMed ID: 25537861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.